← Back to Search

House Call for Chronic Kidney Disease (HC+PM Trial)

N/A

Waitlist Available

Led By James R Rodrigue, Ph.D.

Research Sponsored by Beth Israel Deaconess Medical Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 1 year post-intervention

Awards & highlights

HC+PM Trial Summary

This trial will study whether an educational intervention combined with peer mentorship can raise rates of live donor kidney transplantation, especially for black patients.

Eligible Conditions

Chronic Kidney Disease
Kidney Failure

HC+PM Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 1 year post-intervention

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~1 year post-intervention

This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year post-intervention for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Live donor kidney transplants

Secondary outcome measures

Live donor evaluations

Live donor inquiries

Other outcome measures

Greater amount of time spent discussing LDKT and higher quality interactions measured through the Talking About Living Donation (TaLKeD) instrument

Kidney

Improvement in live donor kidney transplant readiness measured through Living Donation Kidney Transplant Readiness scale (LDKT-R) score

+3 more

HC+PM Trial Design

3Treatment groups

Experimental Treatment

Active Control

Group I: UC + HC + Peer MentorshipExperimental Treatment2 Interventions

Patients in this condition will receive the Usual Care and the House Calls intervention as described previously. In addition, participants will receive access to a Peer Mentor trained by the National Kidney Foundation following their House Call.

Group II: Usual CareActive Control1 Intervention

All enrolled patients will receive Usual Care for transplant candidates at our two centers, which includes individual meetings with transplant providers, attendance at a patient group education session in the transplant center (focused on the specifics of the transplant experience), and a transplant education binder.

Group III: Usual Care (UC) + House Calls (HC)Active Control1 Intervention

Patients and their invited guests will be scheduled for one House Call. A house call is meeting done at a patient's home with transplant health educators facilitating a discussion on topics related to living kidney donation. Patients and guests also receive an information packet containing several brochures providing information about the living donation process, common concerns and misperceptions, and donation resources and information about our transplant center (e.g., copy of our quarterly newsletter, contact information). Patients in the group will also receive Usual Care, the regular education on living donation, provided as part of their routine transplant care.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Peer Mentorship

2018

N/A

~320

House Call

2018

N/A

~320

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Medical University of South CarolinaOTHER

932 Previous Clinical Trials

7,394,070 Total Patients Enrolled

Patient-Centered Outcomes Research InstituteOTHER

550 Previous Clinical Trials

29,996,628 Total Patients Enrolled

Beth Israel Deaconess Medical CenterLead Sponsor

836 Previous Clinical Trials

13,009,910 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is enrollment for this experiment still possible?

"The trial is open for enrollment, as the data on clinicaltrials.gov indicates. This medical research was initially posted on April 30th 2018 and has recently been revised (June 15th 2021)."

Answered by AI

What is the uppermost threshold for participant enrollment in this clinical trial?

"Indeed, research hosted on clinicaltrials.gov demonstrates that this medical trial is actively enrolling patients. This study first appeared online on April 30th 2018 and was last adjusted June 15 2021. A total of 374 individuals will be recruited from two locations."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

House Calls and Peer Mentorship

James Rodrigue 2018. "House Calls and Peer Mentorship". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03354910.